Exelixis (NASDAQ: EXEL) reported Q1 EPS of ($0.27), $0.02 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $15.4 million versus the consensus estimate of $9.11 million.

For earnings history and earnings-related data on Exelixis (EXEL) click here.